Revelation Biosciences, Inc.
REVB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001810560
No open-market purchases or sales by Revelation Biosciences, Inc. insiders were filed in the last 90 days; 12 institutions reported holding it in 13F filings for Q2 2026, worth $313.2K in total; no superinvestor holds it.
Other share classesREVBW
Q1 2026 vs. Q4 2025
How the institutions holding Revelation Biosciences, Inc. changed between Q4 2025 and Q1 2026.
All holders in Q1 2026All holders in Q4 2025
| Measure | Q4 2025 | Of which not filed for Q1 2026 | Q1 2026 | Change |
|---|---|---|---|---|
| Holders | 14 | 1 | 12 | −1 |
| Shares | 1.23M | 52.5K | 499.7K | −678.8K (−57.6%) |
| Value | $984.3K | $42.0K | $599.8K | −$342.6K (−36.4%) |
1 institution that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so the changes leave them out.
New holders (4)
Institutions that held Revelation Biosciences, Inc. at the end of Q1 2026 but not at the end of Q4 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Vanguard Fiduciary Trust Co | 13,127 | $15.8K | 0.00% |
| Tower Research Capital LLC (TRC) | 4,074 | $4.89K | 0.00% |
| Harbour Investments, Inc. | 41 | $49 | 0.00% |
| Caitong International Asset Management Co., Ltd | 1 | $1 | 0.00% |
Sold out (5)
Institutions that held Revelation Biosciences, Inc. at the end of Q4 2025 and filed for Q1 2026 without it.
| Institution | Shares, Q4 2025 | Value, Q4 2025 |
|---|---|---|
| Citadel Advisors LLC | 54,728 | $43.8K |
| Northern Trust Corp | 21,907 | $17.5K |
| HRT Financial LP | 15,320 | $12.0K |
| Bank of America Corp | 47 | $38 |
| Danske Bank A/S | 1 | $1 |
Not filed for Q1 2026 yet (1)
Institutions that held Revelation Biosciences, Inc. at the end of Q4 2025 and haven't filed a 13F for Q1 2026. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2025 | Value, Q4 2025 |
|---|---|---|
| Vanguard Group Inc | 52,505 | $42.0K |